MedPath

A Comparison of Non-invasive Ventilation Methods Used to Prevent Endotracheal Intubation Due to Apnea in Very Low Birth Weight Infants

Not Applicable
Completed
Conditions
Apnea of Prematurity
Interventions
Device: NCPAP as mode for apnea prevention
Device: NIPPV as rescue mode for apnea prevention
Registration Number
NCT03298035
Lead Sponsor
The University of Texas Health Science Center, Houston
Brief Summary

The purpose of this study is to determine whether nasal intermittent positive pressure ventilation (NIPPV) reduces the need for endotracheal intubation in very low birth weight infants with persistent apnea who fail nasal continuous positive airway pressure (NCPAP).

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
19
Inclusion Criteria
  • Infants born at < 30 weeks gestational age who develop clinically significant apnea while on NCPAP > 6cm H2O or whose team is considering intubation due to apnea. Consider clinically significant apnea as 1 or more events treated with bag-mask ventilation or 3 episodes of apnea requiring stimulation within 1 hour.
  • Infants on maximum caffeine therapy (10mg/kg/day)
Exclusion Criteria
  • Major congenital anomalies including congenital heart disease

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
NCPAP as mode for apnea preventionNCPAP as mode for apnea preventionWith recurrence of apneic events, infants on NCPAP will have changes made in NCPAP settings per the clinical team's discretion in attempt to prevent future apneic events. If apneic events persist despite NCPAP adjustments, clinicians may intubate based on clinical judgment.
NIPPV as rescue mode for apnea preventionNIPPV as rescue mode for apnea preventionWith recurrence of apneic events, infants will be placed on NIPPV with settings and adjustments per the clinical team's discretion. If apneic events persist despite NIPPV placement and setting adjustments, clinicians may intubate based on clinical judgment.
Primary Outcome Measures
NameTimeMethod
Number of Participants Who Were Intubated28 days after randomization
Duration of Intubation28 days after randomization
Secondary Outcome Measures
NameTimeMethod
Number of Participants With Air Leak Disorders36 weeks corrected gestational age

Air leak disorders include pneumothorax and/or pneumomediastinum.

Weight Gain36 weeks corrected gestational age
Number of Apneic Events28 days after randomization
Number of Participants With Bronchopulmonary Dysplasia (BPD)36 weeks corrected gestational age
Length of Hospital Stayabout 10 to 18 weeks
Number of Participants Who Dieduntil discharge (about 10 to 18 weeks) or death
Number of Participants With Necrotizing Enterocolitis (NEC)36 weeks corrected gestational age

Trial Locations

Locations (1)

The University of Texas Health Science Center at Houston

🇺🇸

Houston, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath